A Novel TNF-α Converting Enzyme (TACE) Selective Inhibitor JTP-96193 Prevents Insulin Resistance in KK-A<sup>y</sup> Type 2 Diabetic Mice and Diabetic Peripheral Neuropathy in Type 1 Diabetic Mice-Reference-Cited by-同舟云学术

A Novel TNF-α Converting Enzyme (TACE) Selective Inhibitor JTP-96193 Prevents Insulin Resistance in KK-A^y Type 2 Diabetic Mice and Diabetic Peripheral Neuropathy in Type 1 Diabetic Mice

Published:2019-11-01 Issue:11 Volume:42 Page:1906-1912
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Maekawa Mariko¹,Tadaki Hironobu¹,Tomimoto Daisuke¹,Okuma Chihiro¹,Sano Ryuhei¹,Ishii Yukihito¹,Katsuda Yoshiaki¹,Yoshiuchi Hiromi¹,Kakefuda Reina¹,Ohta Takeshi²,Sasase Tomohiko¹

Affiliation:

1. Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc.

2. Laboratory of Animal Physiology and Functional Anatomy, Graduate School of Agriculture, Kyoto University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/42/11/42_b19-00526/_pdf

Reference30 articles.

1. 1) Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. J. Clin. Invest., 94, 1543–1549 (1994).

2. 2) Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature, 385, 729–733 (1997).